Skip to main content
logo
Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
904.35
+1.45 (0.16%)
At close: Nov 6, 2026, 4:00 PM EST
900.92
-3.43 (-0.38%)
After-hours: Nov 6, 2026, 7:58 PM EST

Regeneron Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash & Equivalents
3,6592,4562,9633,1182,5061,9963,0902,4882,0121,9212,6022,7302,1521,9373,9163,1063,4913,3953,3462,886
Short-Term Investments
5,6425,5395,7915,4875,9375,4745,2596,5247,7857,8887,9188,1157,7616,9915,0434,6363,5304,1713,7052,809
Cash & Short-Term Investments
9,3017,9958,7548,6058,4447,4708,3499,0139,7979,80910,52010,8459,9148,9288,9607,7427,0227,5667,0515,695
Cash Growth (YoY)
10.16%7.03%4.84%-4.52%-13.81%-23.85%-20.63%-16.90%-1.18%9.87%17.41%40.07%41.19%17.99%27.08%35.96%21.32%93.47%101.23%58.76%
Accounts Receivable
7,2066,2805,4835,3565,3285,3065,3265,8445,7905,4643,7395,2993,7923,7183,5785,0234,2683,8883,6645,059
Other Receivables
372.2285.6247.7384.9359304235367.8317.4252.71,483368.51,7931,4031,541305.61,2801,2731,175977.5
Receivables
7,5796,5655,7315,7415,6875,6105,5616,2126,1075,7175,2225,6675,5855,1215,1195,3295,5485,1614,8396,037
Inventory
2,8953,0843,1043,2013,2543,2063,1923,0873,0182,8742,7152,5812,5622,5082,4252,4022,4122,2191,9921,951
Prepaid Expenses
1,008791.5612.9469.2588.9554.5466.1348.4412674.4414.9386.6574.7360.8406.2411.2446.4583.6424.9332.4
Restricted Cash
12.510.285.66.719.82.80.8-7.5---5.5------
Total Current Assets
20,79518,44618,20918,02217,98116,86017,57218,66119,33419,08218,87219,47918,63516,92316,90915,88415,42915,53014,30614,015
Property, Plant & Equipment
5,7285,4595,2665,3665,0024,8414,6944,8174,4394,3064,2264,2244,0063,9233,8813,8343,7043,6383,5563,482
Long-Term Investments
10,37210,63010,52810,59510,70110,4679,6659,0608,6517,9197,0535,4715,8396,4066,1156,6406,0176,4637,1316,878
Other Intangible Assets
1,3161,3101,2871,2571,3811,3521,1671,1491,1201,1021,0591,0391,017953928.7915.5804.1--6.7
Long-Term Deferred Tax Assets
4,5364,3814,1914,0773,8473,5723,4433,3143,0152,8812,7652,5752,3172,1391,9251,7241,4521,3521,140876.9
Other Long-Term Assets
1,6601,5051,3881,2411,2581,1281,004758.8883.2797396.5291.8349.1314.9301.3216.9271.9222.6215.3176.1
Total Assets
44,40541,73140,86940,55940,16938,21937,54537,75937,44236,08734,37033,08032,16330,65830,06029,21527,67827,20626,34925,435

Liabilities

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Accounts Payable
1,1401,1591,027939903.8723.9705.5789.5497.3561.7671.3606.6536.6547.3599.5589.2535.6534.2470.3564
Accrued Expenses
3,5922,9672,7242,4872,9762,4612,2422,2842,5372,3612,3932,3272,5332,1762,0742,0541,7961,9282,0461,593
Current Portion of Leases
72072072037.8---30.3---19---12.4---719.7
Current Income Taxes Payable
---351.3---213.2---11.7-------326.3
Current Unearned Revenue
749.8684.8636.2553545.6481.9619.3627.7627.2586516.7458.9528.8381.1426.3485.3547.2572.1491.3442
Other Current Liabilities
-------------------287.4
Total Current Liabilities
6,2025,5315,1084,3684,4253,6673,5673,9443,6613,5093,5813,4233,5993,1043,1003,1412,8793,0343,0083,933
Long-Term Debt
1,9871,9871,9861,9861,9861,9851,9851,9841,9841,9841,9831,9831,9831,9821,9821,9811,9811,9811,9801,980
Long-Term Leases
---949720720720924.1720720720788.7720720720775.8720720720-
Long-Term Unearned Revenue
220.2220.4225.1208.7219.2206.3211.8185.7207.4205.6185.8126.7125.3116.285.569.860.158.733.573.3
Other Long-Term Liabilities
2,4972,2822,1261,7901,8621,7021,6741,3671,5441,463908.5785.4832.4716.8677.3582.2598.6724.7692.5680.2
Total Liabilities
10,90710,0199,4459,3029,2128,2808,1588,4068,1167,8817,3797,1077,2596,6406,5656,5516,2396,5186,4346,666

Shareholders' Equity

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Common Stock
0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.1
Additional Paid-In Capital
15,17314,70114,40113,99513,78713,49113,19212,85612,70312,31711,94311,35411,25210,88910,5989,9499,5189,1208,7548,088
Retained Earnings
39,47237,62136,42435,79735,04633,68032,38431,67330,75529,41527,98227,26026,10125,09324,12523,30722,11020,79419,94218,968
Treasury Stock
-20,949-20,575-19,414-18,613-17,944-17,285-16,218-15,167-14,192-13,456-12,857-12,560-12,271-11,766-11,046-10,353-9,914-9,003-8,611-8,261
Comprehensive Income & Other
-197.5-35.811.977.56952.529.1-7.960.2-69.9-77.2-80.9-176.8-197.7-181.6-238.8-275.1-223.8-170.1-26.2
Shareholders' Equity
33,49931,71131,42431,25730,95829,93929,38829,35429,32628,20626,99125,97324,90424,01823,49522,66421,43920,68819,91518,769
Total Liabilities & Equity
44,40541,73140,86940,55940,16938,21937,54537,75937,44236,08734,37033,08032,16330,65830,06029,21527,67827,20626,34925,435

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Total Debt
2,7072,7072,7062,9732,7062,7052,7052,9392,7042,7042,7032,7912,7032,7022,7022,7702,7012,7012,7002,700
Net Cash (Debt)
16,15215,11615,83415,89316,02414,82314,92114,97415,58314,82814,79513,45112,99012,55312,32511,56510,28911,28211,4349,833
Net Cash Growth (YoY)
0.80%1.98%6.12%6.14%2.83%-0.03%0.85%11.32%19.97%18.12%20.04%16.31%26.24%11.27%7.79%17.61%17.99%120.62%162.81%144.18%
Net Cash Per Share
152.95142.61147.01147.84149.48136.49134.18131.58134.11128.49128.54118.20114.55110.21108.11101.4491.2298.96101.1086.86
Filing Date Shares Outstanding
100.3599.85101.74102.62102.6103.49105.47106.82107.59107.93107.89107.46106.35105.96107.11106.73106.8106.91107.75106.44
Total Common Shares Outstanding
100.32100.32101.92102.6102.8103.92105.7107.1107.8107.9107.9107.12106.22106.3107.1107106.7107.4107.41106.57
Working Capital
14,59312,91513,10213,65413,55613,19314,00514,71715,67315,57315,29116,05615,03613,81913,80912,74312,54912,49611,29810,082
Book Value Per Share
333.93316.11308.32304.65301.15288.10278.03274.08272.04261.41250.15242.47234.46225.94219.38211.81200.93192.62185.41176.11
Tangible Book Value
32,18330,40230,13730,00029,57728,58728,22128,20528,20627,10425,93224,93523,88723,06522,56721,74920,63520,68819,91518,762
Tangible Book Value Per Share
320.81303.05295.70292.39287.71275.10266.99263.35261.65251.19240.34232.78224.89216.98210.70203.26193.39192.62185.41176.05
Land
---278.8---288.2---283.1---264.5---248
Buildings
---3,106---2,573---2,423---2,270---2,089
Machinery
---2,285---2,149---1,940---1,803---1,662
Construction In Progress
---1,890---1,722---1,345---980.5---767.7
Leasehold Improvements
---174.4---154.5---133.9---114.3---113.9
SEC Filings: 10-K · 10-Q